Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-31 |
filingDate |
2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102127180-B1 |
titleOfInvention |
Drug for preventing and/or treating polycystic kidney disease |
abstract |
It is an object of the present invention to provide a combination drug having a remarkably excellent prophylactic and/or therapeutic effect against polycystic kidney disease. The present invention provides a drug for preventing and/or treating polycystic kidney disease, comprising a combination of tolvaptan or a prodrug thereof and a somatostatin derivative, and a method for treating polycystic kidney disease using such a drug. |
priorityDate |
2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |